Unicycive Therapeutics Inc (UNCY) has fallen Wednesday morning, with the stock declining -6.33% in pre-market trading to 2.07. UNCY's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market. In the Biotechnology industry, which ranks 120 out of 146 industries, UNCY ranks higher than 99% of stocks. Unicycive Therapeutics Inc has risen 301.82% over the past month, closing at $0.56 on February 15. During this period of time, the stock fell as low as $0.47 and as high as $2.87. UNCY has an average analyst recommendation of Strong Buy. The company has an average price target of $8.00.
UNCY has an Overall Score of 91. Find out what this means to you and get the rest of the rankings on UNCY!